4 results
To evaluate the feasibility and usability of the adapted Lifestyle-integrated Functional Exercise Programme (aLiFE) and the enhanced LiFE (eLiFE) intervention, versus a control group, in a population of young old adults (61-70 years) at three sites…
To evaluate the feasibility and acceptability of the enhanced Lifestyle-integrated Functional Exercise Programme (eLiFE) intervention in a population of young old adults (60-70 years) at three sites: Stuttgart, Amsterdam, and Trondheim.
To compare overall survival (OS) of patients with metastatic (Stage IV) PDAC treated with BBI-608 plus weekly nab-paclitaxel with gemcitabine versus weekly nab-paclitaxel with gemcitabine.
Primary objective of the study:* To compare overall survival (OS) in the General Population patients treated with BBI-608 plus biweekly FOLFIRI (Arm 1) versus biweekly FOLFIRI (Arm 2)* To compare OS in the pSTAT3-positive (pSTAT3(+)) Subpopulation…